BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 12403768)

  • 1. SHP2 and SOCS3 contribute to Tyr-759-dependent attenuation of interleukin-6 signaling through gp130.
    Lehmann U; Schmitz J; Weissenbach M; Sobota RM; Hortner M; Friederichs K; Behrmann I; Tsiaris W; Sasaki A; Schneider-Mergener J; Yoshimura A; Neel BG; Heinrich PC; Schaper F
    J Biol Chem; 2003 Jan; 278(1):661-71. PubMed ID: 12403768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Negative regulation of gp130 signalling mediated through tyrosine-757 is not dependent on the recruitment of SHP2.
    Fairlie WD; De Souza D; Nicola NA; Baca M
    Biochem J; 2003 Jun; 372(Pt 2):495-502. PubMed ID: 12593670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TNF-alpha induces tyrosine phosphorylation and recruitment of the Src homology protein-tyrosine phosphatase 2 to the gp130 signal-transducing subunit of the IL-6 receptor complex.
    Bode JG; Schweigart J; Kehrmann J; Ehlting C; Schaper F; Heinrich PC; Häussinger D
    J Immunol; 2003 Jul; 171(1):257-66. PubMed ID: 12817006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SOCS3 exerts its inhibitory function on interleukin-6 signal transduction through the SHP2 recruitment site of gp130.
    Schmitz J; Weissenbach M; Haan S; Heinrich PC; Schaper F
    J Biol Chem; 2000 Apr; 275(17):12848-56. PubMed ID: 10777583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the protein tyrosine phosphatase SHP2 via the interleukin-6 signal transducing receptor protein gp130 requires tyrosine kinase Jak1 and limits acute-phase protein expression.
    Schaper F; Gendo C; Eck M; Schmitz J; Grimm C; Anhuf D; Kerr IM; Heinrich PC
    Biochem J; 1998 Nov; 335 ( Pt 3)(Pt 3):557-65. PubMed ID: 9794795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signal transduction of IL-6, leukemia-inhibitory factor, and oncostatin M: structural receptor requirements for signal attenuation.
    Anhuf D; Weissenbach M; Schmitz J; Sobota R; Hermanns HM; Radtke S; Linnemann S; Behrmann I; Heinrich PC; Schaper F
    J Immunol; 2000 Sep; 165(5):2535-43. PubMed ID: 10946280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential inhibition of IL-6-type cytokine-induced STAT activation by PMA.
    Terstegen L; Maassen BG; Radtke S; Behrmann I; Schaper F; Heinrich PC; Graeve L; Gatsios P
    FEBS Lett; 2000 Jul; 478(1-2):100-4. PubMed ID: 10922477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the inhibitors of interleukin-6 signal transduction SHP2 and SOCS3 for desensitization of interleukin-6 signalling.
    Fischer P; Lehmann U; Sobota RM; Schmitz J; Niemand C; Linnemann S; Haan S; Behrmann I; Yoshimura A; Johnston JA; Müller-Newen G; Heinrich PC; Schaper F
    Biochem J; 2004 Mar; 378(Pt 2):449-60. PubMed ID: 14611646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual signaling role of the protein tyrosine phosphatase SHP-2 in regulating expression of acute-phase plasma proteins by interleukin-6 cytokine receptors in hepatic cells.
    Kim H; Baumann H
    Mol Cell Biol; 1999 Aug; 19(8):5326-38. PubMed ID: 10409724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-6-induced proliferation of pre-B cells mediated by receptor complexes lacking the SHP2/SOCS3 recruitment sites revisited.
    Friederichs K; Schmitz J; Weissenbach M; Heinrich PC; Schaper F
    Eur J Biochem; 2001 Dec; 268(24):6401-7. PubMed ID: 11737194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppressor of cytokine signaling-3 preferentially binds to the SHP-2-binding site on the shared cytokine receptor subunit gp130.
    Nicholson SE; De Souza D; Fabri LJ; Corbin J; Willson TA; Zhang JG; Silva A; Asimakis M; Farley A; Nash AD; Metcalf D; Hilton DJ; Nicola NA; Baca M
    Proc Natl Acad Sci U S A; 2000 Jun; 97(12):6493-8. PubMed ID: 10829066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Desensitization of signaling by oncostatin M in human vascular cells involves cytoplasmic Tyr residue 759 in gp130 but is not mediated by either Src homology 2 domain-containing tyrosine phosphatase 2 or suppressor of cytokine signaling 3.
    Mahboubi K; Kirkiles-Smith NC; Karras J; Pober JS
    J Biol Chem; 2003 Jul; 278(27):25014-23. PubMed ID: 12724316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The tyrosine 974 within the LIF-R-chain of the gp130/LIF-R heteromeric receptor complex mediates negative regulation of LIF signalling.
    Clahsen T; Lehmann U; Stross C; Hermanns HM; Volkmer-Engert R; Schneider-Mergener J; Heinrich PC; Schaper F
    Cell Signal; 2005 May; 17(5):559-69. PubMed ID: 15683731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of SOCS3 phosphorylation upon interleukin-6 stimulation. Contributions of Src- and receptor-tyrosine kinases.
    Sommer U; Schmid C; Sobota RM; Lehmann U; Stevenson NJ; Johnston JA; Schaper F; Heinrich PC; Haan S
    J Biol Chem; 2005 Sep; 280(36):31478-88. PubMed ID: 16000307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reciprocal regulation of gastrointestinal homeostasis by SHP2 and STAT-mediated trefoil gene activation in gp130 mutant mice.
    Tebbutt NC; Giraud AS; Inglese M; Jenkins B; Waring P; Clay FJ; Malki S; Alderman BM; Grail D; Hollande F; Heath JK; Ernst M
    Nat Med; 2002 Oct; 8(10):1089-97. PubMed ID: 12219085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Independent roles of SOCS-3 and SHP-2 in the regulation of neuronal gene expression by leukemia inhibitory factor.
    Bartoe JL; Nathanson NM
    Brain Res Mol Brain Res; 2002 Nov; 107(2):108-19. PubMed ID: 12425940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein tyrosine phosphatase 2 (SHP-2) moderates signaling by gp130 but is not required for the induction of acute-phase plasma protein genes in hepatic cells.
    Kim H; Hawley TS; Hawley RG; Baumann H
    Mol Cell Biol; 1998 Mar; 18(3):1525-33. PubMed ID: 9488469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gab1 acts as an adapter molecule linking the cytokine receptor gp130 to ERK mitogen-activated protein kinase.
    Takahashi-Tezuka M; Yoshida Y; Fukada T; Ohtani T; Yamanaka Y; Nishida K; Nakajima K; Hibi M; Hirano T
    Mol Cell Biol; 1998 Jul; 18(7):4109-17. PubMed ID: 9632795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of the interleukin-6 receptor subunit glycoprotein 130 complex and its signaling by LMO4 interaction.
    Novotny-Diermayr V; Lin B; Gu L; Cao X
    J Biol Chem; 2005 Apr; 280(13):12747-57. PubMed ID: 15677447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different protein turnover of interleukin-6-type cytokine signalling components.
    Siewert E; Müller-Esterl W; Starr R; Heinrich PC; Schaper F
    Eur J Biochem; 1999 Oct; 265(1):251-7. PubMed ID: 10491180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.